Table 3 Individual and combined WMD, ORs and 95% CIs by IGF-I and IGFBP-3
From: IGF-I and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested case-control studies
References | IGF-1 | IGFBP-3 | ||
|---|---|---|---|---|
| Â | WMD(95%CI) | OR(95%CI) | WMD(95%CI) | OR(95%CI) |
[14] | --- | 0.54(0.14,2.07) | --- | 0.90(0.28,2.85) |
[15] | -4.00(-10.71,2.71) | 0.86(0.47,1.57) | -70.00(-141.14,1.14) | 0.50(0.25,1.02) |
[16] | 5.00(-5.65,15.65) | 0.64(0.3,11.33) | 1300.00(-259.41,2859.41) | 2.35(1.13,4.92) |
[17] | -2.00(-9.69,5.69) | 1.74(1.08,2.81) | -210.00(-332.13,-87.87) | 0.67(0.45,1.01) |
[18] | -8.30(-17.16,0.56) | 0.76(0.39,1.49) | -141.00(-250.77,-31.23) | 0.71(0.35,1.47) |
[19] | --- | 1.21(0.62,2.35) | --- | 1.70(0.87,3.30) |
Totol effect | -3.04(-7.10,1.02) | 0.87(0.60,1.13) | -112.28(-165.88,-58.68) | 0.68(0.48,0.88) |